Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Procter & Gamble

This article was originally published in The Rose Sheet

Executive Summary

Company confirms its sales and earnings guidance for the second quarter of fiscal year 2007, projecting sales growth of 5%-8% and organic sales growth of 4%-7%. The company will announce final results for the quarter Jan. 30, 2007. Q1 revenue increased 11% to $5.6 bil. due to growth across all categories, P&G said during Dec. 14 analyst call. Organic sales volume in the skin care division was up double digits, driven by the launch of Olay Definity and the performance of OlayRegenerist (1"The Rose Sheet" Nov. 6, 2006, p. 8)...

You may also be interested in...



P&G Q1 Beauty Sales Advance On Performance Of Olay, Pantene

Procter & Gamble beauty division revenues increased 11% to $5.6 bil. for the first quarter of fiscal year 2007 (ended Sept. 30), fueled by growth across all categories and the addition of Gillette products, the company reported in an Oct. 31 earnings release

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel